Arthur He HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
31
Avg Return
Past Year
Past Year
15%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
75%
Neutral
25%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $7 |
270%
upside
| 3 | +0.52% |
0
%
| 15 Aug ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $1.24 |
16%
downside
| 4 | +37% |
0
%
| 5 Aug ‘25 2 months ago |
|
|
|
Buy
Assumed
| $17 |
44%
upside
| 1 | +32% |
0
%
| 30 Jul ‘25 2 months ago |
|
|
|
Neutral
Downgraded
| – | – | 4 | -46% |
0
%
| 29 Jul ‘25 2 months ago |
|
|
|
Buy
Maintained
| $120 |
102%
upside
| 4 | +120% |
0
%
| 24 Jun ‘25 3 months ago |
|
|
|
Buy
Reiterated
| $20 |
233%
upside
| 6 | +2.2% |
0
%
| 17 Jun ‘25 4 months ago |
|
|
|
Buy
Maintained
| $85 |
180%
upside
| 2 | +17% |
0
%
| 2 Jun ‘25 4 months ago |
|
|
|
Neutral
Downgraded
| – | – | 5 | -23% |
0
%
| 20 May ‘25 5 months ago |
|
|
|
Neutral
Reiterated
| – | – | 2 | – |
–
| 31 Mar ‘25 6 months ago |
|
|
|
Neutral
Downgraded
| – | – | 1 | – |
–
| 10 Jan ‘25 9 months ago |
|
|
|
Neutral
Downgraded
| $9 |
5%
downside
| 4 | +6.1% |
0
%
| 26 Nov ‘24 10 months ago |
|